NVS Novartis AG ADR
Healthcare · $150.20 · 52W $121.57–$170.46
Holders
12
Net buyers
+2
Held value
$1.3B
Above 52W low
23.6%
Holders12 Insider buys0 Past moves Open NVS financials →
✦

12 superinvestors hold NVS. In their latest filings 2 opened a position, 4 added and 4 trimmed; the biggest bet is PRIMECAP Management at 0.6% of their book.

Investor % of their book Value Shares Investor 1Y
PMPRIMECAP Management 0.61% $1.0B 6,592,124 Reduced −13% +41.9%
Thomas Kahn 0.33% $2.1M 13,186 Reduced −1% +28.0%
Tom Steyer 0.26% $56.9M 363,000 New +31.0%
Larry Robbins 0.25% $13.6M 86,909 New +46.1%
CBCharles Brandes 0.22% $31.0M 197,593 Added +4% +21.7%
D&Dodge & Cox 0.06% $119.0M 759,373 Reduced −89% +3.4%
Lee Ainslie 0.04% $4.4M 27,789 Added +82% +23.8%
Ric Dillon 0.03% $3.9M 24,822 Held +5.7%
Murray Stahl 0.02% $1.7M 10,588 Reduced −4% -31.4%
Cliff Asness 0.01% $44.1M 281,210 Added +20% +25.8%
Joel Greenblatt 0.00% $420,480 2,683 Held +14.0%
Hersh Cohen 0.00% $300,432 1,917 Added +19% +8.5%

Not investment advice. Data may be delayed or inaccurate.